UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION
 
AND NOTICE OF TERMINATION
 
OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
 
OR
SUSPENSION OF DUTY TO FILE REPORTS
 
UNDER SECTIONS 13 AND 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number 001-41058
 
VAXXINITY,
 
INC.
(Exact name of registrant as specified in its charter)
 
505 Odyssey Way
Merritt Island, FL 32953
(254) 244-5739
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive
 
offices)
 
Class A Common Stock, par value $0.0001 per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for
 
which
a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to
 
terminate or
suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
 
☒
 
Rule 12g-4(a)(2)
 
☐
 
Rule 12h-3(b)(1)(i)
 
☒
 
Rule 12h-3(b)(1)(ii)
 
☐
 
Rule 15d-6
 
☐
 
Rule 15d-22(b)
☐
 
Approximate number of holders of record as of the certification or notice date: 171
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934,
 
as amended, Vaxxinity
 
,
 
Inc. has caused
this certification/notice to be signed on its behalf by the undersigned duly authorized
 
person.
 
 
Date: May 9, 2024
By:
/s/ Mei Mei Hu
 
 
Name:
Mei Mei Hu
 
 
Title:
Chief Executive Officer